ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,664,750 | +95.5% | 215,000 | +152.9% | 3.04% | +155.3% |
| Q2 2023 | $3,921,050 | +1619.8% | 85,000 | +4150.0% | 1.19% | +2487.0% |
| Q1 2021 | $228,000 | -45.1% | 2,000 | -33.3% | 0.05% | -60.7% |
| Q4 2020 | $415,000 | -32.6% | 3,000 | -60.0% | 0.12% | -46.6% |
| Q3 2020 | $616,000 | -39.4% | 7,500 | -42.3% | 0.22% | -44.8% |
| Q2 2020 | $1,017,000 | -41.9% | 13,000 | -67.0% | 0.40% | -90.4% |
| Q1 2020 | $1,749,000 | +6.4% | 39,362 | +2.2% | 4.12% | +232.4% |
| Q4 2019 | $1,644,000 | +60.1% | 38,500 | +60.4% | 1.24% | +24.0% |
| Q3 2019 | $1,027,000 | – | 24,000 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |